Idiopathic Parkinson's disease patients at the urologic clinic
Identifieur interne : 000296 ( Main/Exploration ); précédent : 000295; suivant : 000297Idiopathic Parkinson's disease patients at the urologic clinic
Auteurs : Maged M. Ragab [Égypte] ; Ehab S. Mohammed [Égypte]Source :
- Neurourology and Urodynamics [ 0733-2467 ] ; 2011-09.
English descriptors
Abstract
Aims: To quantitatively evaluate the urinary symptoms at different stages of idiopathic Parkinson's disease (IPD) severity and its relation to urodynamic parameters. Methods: This study was conducted on 49 patients with probable IPD to quantitatively evaluate their urinary symptoms using International Prostate Symptom Score and urodynamic tests. Four, 10, 29, 5, and 1 cases were classified as stages 1–5, respectively, according to Hoehn and Yahr staging of IPD severity. Results: The most prevailing urinary symptom in IPD was nocturia (77.5%) followed by urgency (36.7%) and frequency (32.6%). Urodynamic tests revealed neurogenic detrusor overactivity in 33 patients (67.3%), detrusor underactivity in 6 patients (12.2%), and 10 (20.4%) patients with normal detrusor function. Irritative symptom index score correlated significantly with disease severity as well as the volume at initial desire to void and maximum bladder capacity meanwhile obstructive symptom index score had no significant correlation with any of the urodynamic parameters or disease severity. Total IPSS symptoms score significantly correlated with quality of life score. The mean of urodynamic parameters did not differ in IPD patients who did or did not receive anticholinergic or dopaminergic drugs. Conclusion: The irritative urinary symptoms manifested urodynamically as neurogenic detrusor overactivity are more common in IPD patients than obstructive symptoms. These irritative symptoms deteriorate progressively with the disease severity and significantly affect the quality of life of these patients. The International Prostate Symptom Score is a valuable tool in evaluating the urinary dysfunction in such patients. Neurourol. Urodynam. 30:1258–1261, 2011. © 2011 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/nau.20983
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Idiopathic Parkinson's disease patients at the urologic clinic</title><author><name sortKey="Ragab, Maged M" sort="Ragab, Maged M" uniqKey="Ragab M" first="Maged M." last="Ragab">Maged M. Ragab</name></author><author><name sortKey="Mohammed, Ehab S" sort="Mohammed, Ehab S" uniqKey="Mohammed E" first="Ehab S." last="Mohammed">Ehab S. Mohammed</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F47CA4A916A333ED5A779C052CF6640E1974A75F</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/nau.20983</idno><idno type="url">https://api.istex.fr/document/F47CA4A916A333ED5A779C052CF6640E1974A75F/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001A88</idno><idno type="wicri:Area/Main/Curation">001829</idno><idno type="wicri:Area/Main/Exploration">000296</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Idiopathic Parkinson's disease patients at the urologic clinic</title><author><name sortKey="Ragab, Maged M" sort="Ragab, Maged M" uniqKey="Ragab M" first="Maged M." last="Ragab">Maged M. Ragab</name><affiliation wicri:level="1"><country xml:lang="fr">Égypte</country><wicri:regionArea>Department of Urology, Tanta University, Tanta</wicri:regionArea><wicri:noRegion>Tanta</wicri:noRegion></affiliation></author><author><name sortKey="Mohammed, Ehab S" sort="Mohammed, Ehab S" uniqKey="Mohammed E" first="Ehab S." last="Mohammed">Ehab S. Mohammed</name><affiliation wicri:level="1"><country xml:lang="fr">Égypte</country><wicri:regionArea>Department of Neurology, Tanta University, Tanta</wicri:regionArea><wicri:noRegion>Tanta</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Neurourology and Urodynamics</title><title level="j" type="abbrev">Neurourol. Urodyn.</title><idno type="ISSN">0733-2467</idno><idno type="eISSN">1520-6777</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-09">2011-09</date><biblScope unit="volume">30</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="1258">1258</biblScope><biblScope unit="page" to="1261">1261</biblScope></imprint><idno type="ISSN">0733-2467</idno></series><idno type="istex">F47CA4A916A333ED5A779C052CF6640E1974A75F</idno><idno type="DOI">10.1002/nau.20983</idno><idno type="ArticleID">NAU20983</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0733-2467</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>International Prostate Symptom Score</term><term>Parkinson's disease</term><term>urodynamic</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Aims: To quantitatively evaluate the urinary symptoms at different stages of idiopathic Parkinson's disease (IPD) severity and its relation to urodynamic parameters. Methods: This study was conducted on 49 patients with probable IPD to quantitatively evaluate their urinary symptoms using International Prostate Symptom Score and urodynamic tests. Four, 10, 29, 5, and 1 cases were classified as stages 1–5, respectively, according to Hoehn and Yahr staging of IPD severity. Results: The most prevailing urinary symptom in IPD was nocturia (77.5%) followed by urgency (36.7%) and frequency (32.6%). Urodynamic tests revealed neurogenic detrusor overactivity in 33 patients (67.3%), detrusor underactivity in 6 patients (12.2%), and 10 (20.4%) patients with normal detrusor function. Irritative symptom index score correlated significantly with disease severity as well as the volume at initial desire to void and maximum bladder capacity meanwhile obstructive symptom index score had no significant correlation with any of the urodynamic parameters or disease severity. Total IPSS symptoms score significantly correlated with quality of life score. The mean of urodynamic parameters did not differ in IPD patients who did or did not receive anticholinergic or dopaminergic drugs. Conclusion: The irritative urinary symptoms manifested urodynamically as neurogenic detrusor overactivity are more common in IPD patients than obstructive symptoms. These irritative symptoms deteriorate progressively with the disease severity and significantly affect the quality of life of these patients. The International Prostate Symptom Score is a valuable tool in evaluating the urinary dysfunction in such patients. Neurourol. Urodynam. 30:1258–1261, 2011. © 2011 Wiley‐Liss, Inc.</div></front></TEI><affiliations><list><country><li>Égypte</li></country></list><tree><country name="Égypte"><noRegion><name sortKey="Ragab, Maged M" sort="Ragab, Maged M" uniqKey="Ragab M" first="Maged M." last="Ragab">Maged M. Ragab</name></noRegion><name sortKey="Mohammed, Ehab S" sort="Mohammed, Ehab S" uniqKey="Mohammed E" first="Ehab S." last="Mohammed">Ehab S. Mohammed</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000296 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000296 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:F47CA4A916A333ED5A779C052CF6640E1974A75F
|texte= Idiopathic Parkinson's disease patients at the urologic clinic
}}
| This area was generated with Dilib version V0.6.23. |  |